Company Overview
Snapshot
Founded in August 2009 by Michael Tavger, Tavger operates with 1–10 employees. The company focuses on developing and manufacturing medical devices for various applications, including surgical infection prevention, chronic wound treatment, and medical aesthetics. Tavger offers products like Affinity GJS and BioRef, which are currently released.
Business overview
Tavger specializes in bioengineering solutions for skin quality improvement, developing and manufacturing medical devices for diverse applications. Its core technology enables deep 3D chemical peeling by delivering AHA acids into the dermis without affecting the skin's surface, allowing for year-round procedures. The company serves the medical aesthetics market, alongside providing solutions for surgical infection prevention and chronic wound care, operating within the Health Tech & Life Sciences sector, specifically in.
Log in to access full profile ›Company Intelligence Q&A
- Who founded Tavger?
- Tavger was founded by Michael Tavger, who serves as Co-founder & CEO.
- What is Tavger's primary focus in medical applications?
- Tavger designs and manufactures devices for preventing or mitigating surgical infection sites, treating chronic wounds in outpatient clinics and nursing care, and facilitating patient home wound care.
- What is Tavger's core technology for skin treatment?
- Tavger's technology performs deep 3D chemical peeling by delivering relatively weak AHA acids to the dermis, which can be adjusted for amount and depth depending on indications and the treated area. This process does not affect the skin's surface.
- What are some of the products offered by Tavger?
- Tavger offers several products, including Affinity GJS, BioRef, Affinity, MesostripS, and MesoStripD.
- In which sector does Tavger primarily operate?
- Tavger operates primarily in the Health Tech & Life Sciences sector, with a focus on Medical Devices, Aesthetic Devices, and Medical Treatment & Therapeutics.